New study shows Vitamin D reduces risk of hospitalization by 14X. Markets staging "mini buyers" strike ahead of CPI data

Click HERE to access the FSInsight COVID-19 Daily Chartbook.

We publish on a 4-day a week schedule:


STRATEGY: Stocks tread water, but we still expect Feb to be a rally month

Positivity rate is dipping and below 10% within a few days
In the latest sign of the rapid abatement of Omicron, the overall positivity rate in the US is plunging. After surging to a whopping 35% in January, the spot positivity rate is down to under 10%. And while 10% is hardly great, it is a level seen as "contained" -- of course, the key is how much further positivity rate will fall.

The video in this report is only accessible to members

Another study reinforces role of Vitamin D mitigating COVID-19 -- reduces risk of hospitalization by 14X

A study published in PLOS ONE shows the connection between Vitamin D and the risks of COVID-19. This study encompassed 1,100 participants:

- this is the first comprehensive study to look at Vit D levels prior to infection
- those with Vit D deficiency were 14X more likely to be hospitalized
- Vit D deficient group also had a mortality rate of 23.6% vs 2.3% with sufficient Vit D

As many of our clients know, our firm has highlighted multiple studies of Vitamin D sufficiency and its ability to mitigate the risks of COVID-19 and this study further rein...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Don't Miss Out
First Month Free